Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector
- 1 June 1998
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 5 (6) , 809-819
- https://doi.org/10.1038/sj.gt.3300643
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 0 references indexed in Scilit: